|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07C 69/753 | (2006.01) |
| C07J 63/00 | (2006.01) | ||
| A61K 31/56 | (2006.01) | ||
| A61P 31/18 | (2006.01) |
| (11) | Number of the document | 2791103 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12857774.9 |
| Date of filing the European patent application | 2012-12-14 | |
| (97) | Date of publication of the European application | 2014-10-22 |
| (45) | Date of publication and mention of the grant of the patent | 2017-08-02 |
| (46) | Date of publication of the claims translation | 2017-10-25 |
| (86) | Number | PCT/US2012/069637 |
| Date | 2012-12-14 |
| (87) | Number | WO 2013/090664 |
| Date | 2013-06-20 |
| (30) | Number | Date | Country code |
| 201161576448 P | 2011-12-16 | US |
| (72) |
HATCHER, Mark Andrew, US
JOHNS, Brian, Alvin, US
MARTIN, Michael, Tolar, US
TABET, Elie, Amine, US
TANG, Jun, US
|
| (73) |
GlaxoSmithKline LLC,
251 Little Falls Drive, Wilmington, DE 19808,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Betulino dariniai |
| DERIVATIVES OF BETULIN |
| Payment date | Validity (years) | Amount | |
| 2019-12-05 | 8 | 185.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-12-14 |